INTERNATIONAL PATENT: SHANGHAI YINGLI PHARMACEUTICAL CO., LTD, 上海璎黎药业有限公司 FILES APPLICATION FOR "NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF"

GENEVA, April 17 -- SHANGHAI YINGLI PHARMACEUTICAL CO., LTD (Floor 2, Building 8, No.2555 Xiupu RoadPudong New Area, Shanghai 201315), 上海璎黎药业有限公司 (中国上海市浦东新区秀浦路2555号8幢2层) filed a patent application (PCT/CN2025/126363) for "NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF" on Oct 06, 2025. With publication no. WO/2026/077361, the details related to the patent application was published on Apr 16, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by...